Olympia Pharmaceuticals
A March 2022 recall of 11 lots (including Sermorelin and NAD) was closed out; Form 483i inspections in May 2024 and August 2025 raised quality observations, addressed at the time of inspection.
About this pharmacy
Facility type: 503A/503B — licensed as both a state compounding pharmacyi and an FDA-registered outsourcing facility.
The four standards
Holds LegitScripti accreditation.
In March 2022, Olympia voluntarily recalledi 11 lots nationwide — including Sermorelin and NAD, both current Kongo product lines — for out-of-specification potency and reconstitution-time results. The recall has been closed out. FDA issued Form 483 inspection reports in May 2024 and August 2025, each raising quality observations. No warning letteri has been issued; the most recent findings were addressed at the time of inspection.
(Method: checked against FDA’s public Form 483, warning-letter, and recall databases.)
Source: FDA recall notice — March 2022
Source: FDA Form 483 — May 2024
Source: FDA Form 483 — August 2025
Operates under its stated legal name, not private-label branding.
Cold-chaini packaging with cooling packs verified.
(Method: direct confirmation via Kongo’s partnership experience — not sourced from public reviews.)
Frequently asked questions
Is Olympia Pharmaceuticals accredited?
Yes. Olympia Pharmaceuticals holds LegitScript accreditation.
Has Olympia Pharmaceuticals had any FDA regulatory actions?
There is an ongoing review. In March 2022, Olympia voluntarily recalled 11 lots nationwide — including Sermorelin and NAD, both current Kongo product lines — for out-of-specification potency and reconstitution-time results. The recall has been closed out. FDA issued Form 483 inspection reports in May 2024 and August 2025, each raising quality observations. No warning letter has been issued; the most recent findings were addressed at the time of inspection. Checked against FDA’s public Form 483, warning-letter, and recall databases.
Is Olympia Pharmaceuticals a Kongo partner?
Yes. Olympia Pharmaceuticals is a current Kongo partner. Kongo applies the same four standards to its own pharmacy partners as to every other pharmacy listed in this directory — no exceptions, no special treatment. Partner status does not change how we evaluate or report on a pharmacy.